BIOMAT Database Logo BIOMAT Database Logo

[Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder]. 1993

F A Offner, and G Schäfer, and A Hittmair, and D Ofner, and K Grünewald, and K Weyrer, and D Mattern, and J Eberle, and G Mikuz, and H Feichtinger
Institut für Pathologische Anatomie, Universität Innsbruck.

Mutations of the p53 gene are important mechanisms in malignant transformation and are associated with dysregulation of normal cell growth. In the present study the expression of mutated p53-protein and proliferating cell nuclear antigen (PCNA) was investigated in a series of 31 human transitional cell carcinomas (TCC) by immunohistochemistry (IHC). The number of PCNA-positive cells and the pattern of expression was distinct in normal urothelium being confined to the basal cell layer. In dysplastic urothelium and in Carcinoma in situ (CIS) PCNA-immunoreactive nuclei were irregularly distributed throughout all layers. In tumor cell complexes the pattern of PCNA-immunoreactivity was different in papillary and primary infiltrating TCCs. Densitometric quantification of the intensity of the PCNA-reactivity using image analysis revealed an increase from normal to dysplastic urothelium and from dysplastic urothelium to invasive tumors. 21/31 (68%) of the tumors and tumor-associated CIS showed overexpression of p53 varying in percentage, pattern and reaction intensity. The percentage of PCNA-positive cells was higher in tumors overexpressing p53. Double IHC showed colocalization of both molecules in a significant proportion of tumor cells suggesting a link of p53 overexpression and the abnormal proliferative activity. The present results show that p53 over-expression is found in a significant percentage of TCCs and indicate a close association with a defective growth regulation resulting in increased PCNA-levels and enhanced cellular proliferation.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002278 Carcinoma in Situ A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane. Carcinoma, Intraepithelial,Carcinoma, Preinvasive,Intraepithelial Neoplasms,Neoplasms, Intraepithelial,Intraepithelial Carcinoma,Intraepithelial Neoplasm,Neoplasm, Intraepithelial,Preinvasive Carcinoma
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor

Related Publications

F A Offner, and G Schäfer, and A Hittmair, and D Ofner, and K Grünewald, and K Weyrer, and D Mattern, and J Eberle, and G Mikuz, and H Feichtinger
p53 protein expression and proliferative activity in imprints of superficial transitional cell carcinoma of the bladder.
June 2000, Analytical and quantitative cytology and histology,
F A Offner, and G Schäfer, and A Hittmair, and D Ofner, and K Grünewald, and K Weyrer, and D Mattern, and J Eberle, and G Mikuz, and H Feichtinger
p53 mutation and bcl-2 expression in transitional cell carcinoma of the urinary bladder.
January 2001, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
F A Offner, and G Schäfer, and A Hittmair, and D Ofner, and K Grünewald, and K Weyrer, and D Mattern, and J Eberle, and G Mikuz, and H Feichtinger
Expression of CD15 antigen in urinary bladder transitional cell carcinoma.
July 1990, Journal of clinical pathology,
F A Offner, and G Schäfer, and A Hittmair, and D Ofner, and K Grünewald, and K Weyrer, and D Mattern, and J Eberle, and G Mikuz, and H Feichtinger
P53 expression, ploidy and progression in pT1 transitional cell carcinoma of the bladder.
May 1994, British journal of urology,
F A Offner, and G Schäfer, and A Hittmair, and D Ofner, and K Grünewald, and K Weyrer, and D Mattern, and J Eberle, and G Mikuz, and H Feichtinger
Expression of CD44s and CD44v6 in transitional cell carcinomas of the urinary bladder: comparison with tumour grade, proliferative activity and p53 immunoreactivity of tumour cells.
November 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
F A Offner, and G Schäfer, and A Hittmair, and D Ofner, and K Grünewald, and K Weyrer, and D Mattern, and J Eberle, and G Mikuz, and H Feichtinger
Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder.
January 1997, British journal of urology,
F A Offner, and G Schäfer, and A Hittmair, and D Ofner, and K Grünewald, and K Weyrer, and D Mattern, and J Eberle, and G Mikuz, and H Feichtinger
Loss of FHIT expression in transitional cell carcinoma of the urinary bladder.
February 2000, The American journal of pathology,
F A Offner, and G Schäfer, and A Hittmair, and D Ofner, and K Grünewald, and K Weyrer, and D Mattern, and J Eberle, and G Mikuz, and H Feichtinger
Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma.
August 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
F A Offner, and G Schäfer, and A Hittmair, and D Ofner, and K Grünewald, and K Weyrer, and D Mattern, and J Eberle, and G Mikuz, and H Feichtinger
c-jun oncogene expression in transitional cell carcinoma of the urinary bladder.
December 1994, British journal of urology,
F A Offner, and G Schäfer, and A Hittmair, and D Ofner, and K Grünewald, and K Weyrer, and D Mattern, and J Eberle, and G Mikuz, and H Feichtinger
E-cadherin expression in papillary transitional cell carcinoma of the urinary bladder.
September 1995, Human pathology,
Copied contents to your clipboard!